These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15255405)

  • 41. Narrating genetic disabilities: social constructs, medical treatment, and public policy.
    Squier SM
    Issues Law Med; 1999; 15(2):141-58. PubMed ID: 10597661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curing the stigma of leprosy.
    Rafferty J
    Lepr Rev; 2005 Jun; 76(2):119-26. PubMed ID: 16038245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Awareness about the persons with disability act among leprosy patients and other disabled persons.
    Robins R; Martin D; Raj KD; Raju MS
    Indian J Lepr; 2006; 78(3):217-29. PubMed ID: 17120505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfer of disability care of leprosy to the affected persons and the community members.
    Porichha D; Rao VN; Samal P; Rao AK
    Indian J Lepr; 2011; 83(2):81-6. PubMed ID: 21972660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychodynamic understanding and treatment of patients with congenital disability.
    Thomas KR; Kim JH; Rosenthal DA
    Am J Psychoanal; 2020 Dec; 80(4):458-471. PubMed ID: 33268886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of social status of people with disabilities due to leprosy in desert part of Rajasthan, India.
    Yadav SP
    J Commun Dis; 2011 Sep; 43(3):201-7. PubMed ID: 23781633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical certification of leprosy patients and reservation in service for the physically handicapped, including persons with leprosy.
    Mehta JM
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):332-3. PubMed ID: 6449484
    [No Abstract]   [Full Text] [Related]  

  • 48. A three-year leprosy control programme in Tamil Nadu (India).
    Malchow-Moller A
    Dan Med Bull; 1973 Dec; 20(6):198-203. PubMed ID: 4777752
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of Social Determinants of Health and Disability Scores in Leprosy-Affected Persons in Salem, Tamil Nadu, India.
    Heidinger M; Simonnet E; Karippadathu SF; Puchinger M; Pfeifer J; Grisold A
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Portraying a positive image of persons (previously) affected by leprosy.
    van Brakel WH; Gopal PK
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):477-9. PubMed ID: 10700926
    [No Abstract]   [Full Text] [Related]  

  • 51. Government health workers as implementers of prevention of disability measures: an assessment of a prevention of disability project in selected counties of Guizhou Province, Peoples' Republic of China.
    Li J; Mu H; Ke W; Bao X; Wang Y; Shen LM; Cross H
    Lepr Rev; 2008 Sep; 79(3):295-302. PubMed ID: 19009978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Installations for special therapy of ear malformations with hearing damage].
    Paul HA
    Offentl Gesundheitsdienst; 1966 Feb; 28(2):68-73. PubMed ID: 4228701
    [No Abstract]   [Full Text] [Related]  

  • 53. Not by chemotherapy alone.
    Srinivasan H
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):404-11. PubMed ID: 7963914
    [No Abstract]   [Full Text] [Related]  

  • 54. Knowledge and management of disabling conditions in South Asian histories: implications for leprosy futures.
    Miles M
    Indian J Lepr; 2003; 75(2):153-67. PubMed ID: 15255402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A three year leprosy control programme in Tamil Nadu (India).
    Malchow-Moller A
    Dan Med Bull; 1974 Oct; 21(6):256. PubMed ID: 4430192
    [No Abstract]   [Full Text] [Related]  

  • 56. Lessons from the evolution of a CBR programme for people affected by leprosy in Northern Nigeria.
    Ebenso B; Idah M; Anyor T; Opakunmi F
    Lepr Rev; 2010 Dec; 81(4):318-31. PubMed ID: 21313977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A small-group center. A model trial for activities of a center for rare diseases and syndromes at the National Hospital].
    Kase BF; Nilsson B
    Tidsskr Nor Laegeforen; 1996 Apr; 116(11):1340-4. PubMed ID: 8658417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sources of anxiety amongst leprosy patients in urban treatment setting in Hyderabad, India.
    Thwaites V; Anjum V; Rao K
    Lepr Rev; 2014 Dec; 85(4):328-31. PubMed ID: 25675657
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of disability in leprosy: the different levels.
    Brandsma JW
    Indian J Lepr; 2011; 83(1):1-8. PubMed ID: 21638977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of leprosy on the basis of the epidemiology of disabilities.
    Ganapati R; Revankar CR; Kingsley S
    Lepr Rev; 1996 Mar; 67(1):13-7. PubMed ID: 8820515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.